BriaCell Therapeutics Announces Pricing of Public Offering
PHILADELPHIA and VANCOUVER, British Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” ...
BriaCell宣布公开发售普通股
费城和不列颠哥伦比亚省温哥华讯 - 专注于癌症免疫疗法的临床阶段生物技术公司BriaCell Therapeutics Corp.今日宣布计划进行普通股的尽力公开发售。该公司目前市值为250万美元，EBITDA为-422万美元，正积极寻求加强其财务状况。此次发售的完成和具体条款将取决于市场条件，目前尚无法确定发售是否能够完成及其具体细节。
H.C. Wainwright因试验成功将Briacell目标股价上调至32美元
周二，H.C. Wainwright分析师Emily Bodnar将Briacell Therapeutics (NASDAQ: BCTX ...
BriaCell Therapeutics Announces Proposed Public Offering of Common Shares
PHILADELPHIA and VANCOUVER, British Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” ...
BriaCell Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTS™
Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS™ ...
H.C. Wainwright raises Briacell stock target to $32 on trial success
H.C. Wainwright analyst Emily Bodnar increased the price target for Briacell Therapeutics (NASDAQ:BCTX) to $32 from the previous $15, while maintaining a Buy rating on the stock. The company, ...
BriaCell announces resolution of lung metastasis in patient receiving Bria-OTS
Therapeutics announces an unprecedented clinical response including resolution of a lung metastasis with stable disease ...
BriaCell immunotherapy destroys metastatic breast cancer tumor
BriaCell Therapeutics (TSX:BCT) is reporting that the first metastatic breast cancer patient treated with its Bria-OTS ...
BriaCell Therapeutics Shares Hit Record Low After Public Offering News
Shares of BriaCell Therapeutics were trading at all-time lows in Monday's after-hours market, following news the company plans to sell shares in a best-efforts public offering.
BriaCell Therapeutics: Stocks Undervalued by Analyst Consensus on TSX (BCT)
Detailed price information for Briacell Therapeutics Corp (BCT-T) from The Globe and Mail including charting and trades.